Losartan, an angiotensin type 1 receptor antagonist, improves conduit vessel endothelial function in type 2 diabetes

C. Cheetham, G. O'Driscoll, K. Stanton, R. Taylor, Daniel Green

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)13-17
JournalClinical Science
Volume100
Publication statusPublished - 2000

Cite this